Search results
AstraZeneca PLC (OTCMKTS:AZNCF) Sees Large Drop in Short Interest
ETF DAILY NEWS· 5 hours agoAstraZeneca PLC (OTCMKTS:AZNCF – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 31st, there was short interest ...
Why AstraZeneca plc (NASDAQ:AZN) is Investors’ One of Favorite International Dividend Stock?
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since AstraZeneca ...
Ethic Inc. Grows Stake in AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 1 day agoEthic Inc. lifted its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 10.7% in the 4th quarter, according to its most recent 13F filing ...
AstraZeneca CEO gifts shares to family, no sale involved By Investing.com
Investing.com· 23 hours agoAstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN) disclosed in a recent regulatory filing with the...
AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of “Moderate Buy” from Analysts
ETF DAILY NEWS· 3 days agoAstraZeneca PLC (NASDAQ:AZN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering ...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 5 hours agoThe US Food and Drug Administration (FDA) has granted approval for AstraZeneca's Farxiga...
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.
Morningstar· 15 hours agoAstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2 diabetes in children 10 and older. Farxiga, which goes by generic ...
AstraZeneca champions early kidney disease diagnosis with modelling data
Pharmaceutical Technology via Yahoo Finance· 1 day agoAstraZeneca has highlighted both the economic and environmental benefits of implementing early,...
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Investor's Business Daily· 1 hour agoRivals Face Off With Regeneron Stock The companies are far from alone in the burgeoning COPD...
Astrazeneca (AZN) Advances But Underperforms Market: Key Facts
Zacks via Yahoo Finance· 3 days agoAstrazeneca (AZN) closed the most recent trading day at $80.21, moving +0.24% from the previous...